THE POLYMEDCO SPOTCHEM EX GLUCOSE, FRUCTOSAMINE AND AST TESTS
K041427 · Arkray, Inc. · CGA · Nov 24, 2004 · Clinical Chemistry
Device Facts
Record ID
K041427
Device Name
THE POLYMEDCO SPOTCHEM EX GLUCOSE, FRUCTOSAMINE AND AST TESTS
Applicant
Arkray, Inc.
Product Code
CGA · Clinical Chemistry
Decision Date
Nov 24, 2004
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 862.1345
Device Class
Class 2
Attributes
Pediatric
Indications for Use
The SpotChem EZ Glucose, Fructosamine and AST test systems are in vitro diagnostic procedures intended to measure Glucose, Fructosamine, and AST quantitatively in human serum and plasma on the SpotChem EZ Analyzer
Device Story
SpotChem EZ system consists of an analyzer and specific test reagents for glucose, fructosamine, and AST. Device performs in vitro diagnostic measurements on patient samples. Used in clinical settings by healthcare professionals. Provides quantitative results to assist clinicians in diagnosing and managing metabolic, liver, and heart conditions. Enables monitoring of diabetes control and insulin therapy adjustments.
Clinical Evidence
Bench testing only. Method comparison studies performed against predicate devices (Bayer Advia 1650, Roche COBAS MIRA) using serum/plasma samples (N=116 for Glucose, N=76 for Fructosamine, N=100 for AST). Correlation coefficients (r) were 0.985, 0.972, and 0.978 respectively. Matrix comparison studies performed using whole blood (N=31-42) showed high correlation (r=0.9915-0.999). Precision assessed via intra-assay and inter-assay studies; %CVs generally <10%. Analytical specificity tested against hemoglobin, bilirubin, and triglycerides.
Technological Characteristics
Plastic reagent strips with multilayered test fields (sample retention, reagent, support). Principle: reflectance spectrophotometry. Glucose: glucose oxidase/peroxidase colorimetric. Fructosamine: tetrazolium salt colorimetric. AST: enzymatic colorimetric. Dimensions/form factor: reagent strip. Connectivity: intended for use on SpotChem EZ analyzer (k040332).
Indications for Use
Indicated for: Glucose: diagnosis/treatment of carbohydrate metabolism disorders (diabetes mellitus, neonatal hypoglycemia, idiopathic glycemia, pancreatic isle cell carcinoma). Fructosamine: assessment of diabetes control and insulin dosage determination. AST: diagnosis/treatment of liver and heart diseases. Prescription use only.
Regulatory Classification
Identification
A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.
Special Controls
*Classification.* Class II (special controls). The device, when it is solely intended for use as a drink to test glucose tolerance, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
Submission Summary (Full Text)
{0}
1
# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE
A. 510(k) Number: k041427
B. Purpose for Submission: Notification of intent to market 3 assays: SpotChem EZ Glucose, fructosamine, and Aspartate Amino Transferase (AST)
C. Measurand: Glucose, Fructosamine, Aspartate Amino Transferase (AST)
D. Type of Test: quantitative, colorimetric
E. Applicant: Polymedco, Inc.
F. Proprietary and Established Names:
Spotchem EZ Glucose
Spotchem EZ Fructosamine
Spotchem EZ AST
G. Regulatory Information:
1. Regulation section:
Glucose 21 CFR 862.1175 – Glucose Test System
Fructosamine 21 CFR 864.7470 – Glycosylated Hemoglobin Assay
AST 21 CFR 862.1100 – Aspartate Amino Transferase (AST/SGOT) Test System
2. Classification:
Glucose – Class II
Fructosamine – Class II
AST – Class II
3. Product code:
Glucose – CGA, Glucose Oxidase, Glucose
Fructosamine – LCP, Assay, Glycosylated Hemoglobin
AST – CIS, Hydrazone Colorimetry, AST/SGOT
4. Panel:
Glucose, AST – Chemistry 75
Fructosamine – Immunology 82
H. Intended Use:
1. Intended use(s): The SpotChem EZ Glucose, Fructosamine and AST test systems
{1}
are in vitro diagnostic procedures intended to measure Glucose, Fructosamine, and AST quantitatively in human serum and plasma on the SpotChem EZ Analyzer
2. **Indication(s) for use:** Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders, including diabetes mellitus, neonatal hypoglycemia and idiopathic glycemia, and of pancreatic isle cell carcinoma.
Fructosamine measurements are used to assess the level of control of a patient's diabetes and to determine the proper insulin dosage for a patient. Elevated levels of fructosamine indicate uncontrolled diabetes in a patient.
AST measurements are used in the diagnosis and treatment of certain liver and heart diseases.
3. **Special conditions for use statement(s):** for prescription use only
4. **Special instrument requirements:** these assays are intended for use on the previously cleared SpotChem EZ analyzer (k040332).
I. **Device Description:** The Polymedco, Inc SPOTCHEM EZ Glucose, Fructosamine and AST assays are in vitro diagnostic procedures intended to measure Glucose, Fructosamine, and AST quantitatively in human serum and plasma on the SpotChem EZ Analyzer.
The device is composed of plastic strips to which a multilayered test field is affixed. The layers consist of a sample retention layer, a layer containing the reagents and a support layer.
A fixed amount of serum or plasma is placed on the test field of the reagent strip. The plasma or serum spreads in a uniform fashion across the entire surface of the sample retention layer. The serum or plasma then permeates into the reagent layer where the reaction is initiated.
J. **Substantial Equivalence Information:**
1. **Predicate device name(s):**
Bayer Glucose Hexokinase II Assay for Advia 1650
Roche COBAS MIRA Fructosamine Assay
Bayer Aspartate Aminotransferase Assay for Advia 1650
2. **Predicate 510(k) number(s):**
k011963
k003120
k990346
{2}
3. Comparison with predicate:
| | Glucose | Fructosamine | AST |
| --- | --- | --- | --- |
| Predicate Methodology | hexokinase | colorimetric enzyme-based | Colorimetric enzyme-based |
| Test Methodology | Glucose oxidase | colorimetric enzyme-based | Colorimetric enzyme-based |
| Predicate Reagent Storage | 2-8 °C | 2-8 °C | 2-8 °C |
| Test Reagent Storage | 2-8 °C | 2-8 °C | 2-8 °C |
| Predicate Sample types | Serum/Plasma, Whole blood | Serum/Plasma, Whole blood | Serum/Plasma, Whole blood |
| Test Sample Types | Serum/Plasma, Whole blood | Serum/Plasma, Whole blood | Serum/Plasma, Whole blood |
| Predicate Controls | Recommended | Recommended | Recommended |
| Test Controls | Recommended | Recommended | Recommended |
| Correlation with Predicate device | N = 116. Range spanned from 49 – 372 mg/dL. The regression equation was y = 0.9905x – 0.5654 and r = 0.985 | N = 76. Range spanned from 198 – 722 umol/L. The regression equation was y = 0.840x - 21.182 and r = 0.972 | N = 100. Range spanned from 10 - 145 IU/L. The regression equation was y = 0.93x – 0.658 and r = 0.978. |
K. Standard/Guidance Document Referenced (if applicable): N/A
L. Test Principle:
Glucose in the sample is oxidized in a concentration dependent manner by glucose oxidase found in the reagent layer. The glucose oxidase oxidizes the glucose with the quantitative production of hydrogen peroxide. The hydrogen peroxide oxidizes and condenses 4-aminoantipyrine and 1-naphthol-3,6-disulfonic acid disodium by the catalytic action of peroxidase to form a reddish-purple color. During the reaction, the reagent layer is completely dissolved and is absorbed by the sample-retention layer. These two layers thus form a single detection layer. The intensity of the reddish-purple color, as determined by reflectance spectrophotometry, is proportional to the concentration of glucose in the sample.
Fructosamine in the sample reacts with 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyl-2H tetrazolium chloride to generate a red color. During the reaction, the reagent layer is completely dissolved and is absorbed by the sample-retention layer. These two layers thus form a single detection layer. During the reaction, the reagent layer is completely dissolved and is absorbed by the sample-retention layer. These two layers thus form a single detection layer. The rate at which the red color is generated in the detection layer is proportional to the concentration of fructosamine in the sample.
{3}
AST in the sample catalyzes the transfer of the amino group of L-aspartic to alpha-ketoglutaric acid to produce L-glutamic acid and oxalacetic acid. Oxalacetic acid is decarboxylated by oxalic acid decarboxylase to produce pyruvic acid. The pyruvic acid, in the presence of magnesium ion and thiamine pyrophosphoric acid, is oxidized by the catalytic action of pyruvate oxidase to produce hydrogen peroxide. The hydrogen peroxide oxidizes and condenses 4-aminoantipyrine and N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline by the catalytic action of peroxidase to form a blue color. During the reaction, the reagent layer is completely dissolved and is absorbed by the sample-retention layer. These two layers thus form a single detection layer. The rate at which the blue color is generated in the detection layer is proportional to the AST activity in the sample.
## M. Performance Characteristics (if/when applicable):
### 1. Analytical performance:
a. Precision/Reproducibility: Intra-assay precision was assessed by assaying three samples twenty times in one run. Inter-assay precision was assessed by assaying three samples in duplicate in ten runs over ten days. The results are presented in the tables below:
Intra Assay Precision on Spot Chem Analyzer.
| Analyzer Poly Chem | | Level 1 | Level 2 | Level 3 |
| --- | --- | --- | --- | --- |
| Glucose | n | 20 | 20 | 20 |
| | Mean (mg/dL) | 64 | 107 | 267 |
| | SD | 0.73 | 2.49 | 8.71 |
| | %CV | 1.14 | 2.32 | 3.26 |
| Fructosamine | Mean (umol/L) | 202 | 485 | 563 |
| | SD | 9.96 | 22.19 | 21.74 |
| | %CV | 4.93 | 4.58 | 3.86 |
| AST | Mean (IU/L) | 24.27 | 105.95 | 188.5 |
| | SD | 0.967 | 3.694 | 6.525 |
| | %CV | 3.99 | 3.44 | 3.46 |
Inter Assay Precision on Poly-Chem Analyzer.
| Analyzer Poly Chem | | Level 1 | Level 2 | Level 3 |
| --- | --- | --- | --- | --- |
| Glucose | Days | 10 | 10 | 10 |
| | n | 20 | 20 | 20 |
| | Mean (mg/dL) | 63 | 106 | 9.46 |
| | SD | 1.52 | 3.91 | 7.46 |
| | %CV | 2.42 | 3.69 | 3.61 |
| Fructosamine | Mean (umol/L) | 206 | 483 | 578 |
| | SD | 9.21 | 27.66 | 16.86 |
| | %CV | 4.46 | 5.72 | 2.92 |
| AST | Mean (IU/L) | 24.75 | 106.95 | 180.35 |
| | SD | 2.173 | 5.790 | 6.226 |
| | %CV | 8.78 | 5.41 | 3.45 |
{4}
b. Linearity/assay reportable range: The linearity was assessed by assaying serial dilutions. The linearity claim is based on a percent deviation of ≤5% at the two highest concentrations. The results obtained were as follows: Glucose up to 416 mg/dL, Fructosamine up to 617 umol/L, AST up to 859 IU/L
c. Traceability, Stability, Expected values (controls, calibrators, or methods): None provided.
d. Detection limit: Functional sensitivity was assessed by diluting a pool of 10 different concentrations below the lower limit of the analyte range. Three runs were performed over three different days on the SpotChem EZ analyzer. The mean, standard deviation and percent coefficient of variation was calculated for the ten replicates of each dilution. The functional sensitivity of the test was defined as the value of the dilution where the CV is approximately 20% (taking into consideration that the actual mean was within ±10% of the expected target). It was determined that functional sensitivity was 27 mg/dL with a CV reported at 1.3% for Glucose, 102.06 umol/L with a CV of 1,99% for Fructosamine, and 10 IU/L with a CV reported at 0.6% for AST.
e. Analytical specificity: Studies were performed to assess common or known substances that could interfere with the method. A summary of the data or of known interferents appears for the common interferents:
| | Glucose | Fructosamine | AST |
| --- | --- | --- | --- |
| Sample | Highest Level Tested with No Interference | Highest Level Tested with No Interference | Highest Level Tested with No Interference |
| Hemoglobin | 150 mg/dL | 350 mg/dL | 100 mg/dL |
| Bilirubin | 9 mg/dL | 3.0 mg/dL | 1.5 mg/dL |
| Triglycerides | 200 mg/dL | 350 mg/dL | 200 mg/dL |
f. Assay cut-off: N/A
2. Comparison studies:
a. Method comparison with predicate device:
Clinical correlation studies were performed comparing the Glucose and AST results generated on the Spotchem analyzer against results from the Bayer Advia 1650 using serum and plasma samples, and on Fructosamine results generated on the Spotchem analyzer against results from the Roche COBAS MIRA using serum and plasma samples. The correlations were as follows: Glucose y = 0.9905x-0.5654, r = 0.985, n = 116, range = 49-372 mg/dL Fructosamine y = 0.84x-21.18, r = 0.97, n = 76, range = 198-722 umol/L AST y = 0.927x-0.6577, r = 0.978, n = 100, range = 10-145 IU/L
{5}
b. Matrix comparison:
Clinical correlation studies were performed comparing the Glucose and AST results generated against whole blood samples when performed on the Spotchem analyzer. The correlations were as follows:
Glucose y = 0.9909x + 0.3761, r = 0.999, n = 31, range = 65-311 mg/dL
Fructosamine y = 1.020x - 0.615, r = 0.9915, n = 42, range = 35-414 umol/L
AST y = 0.999x + 0.864, r = 0.999, n = 33, range = 10 - 545 IU/L
3. Clinical studies:
a. Clinical Sensitivity: N/A
b. Clinical specificity: N/A
c. Other clinical supportive data (when a. and b. are not applicable): N/A
4. Clinical cut-off: N/A
5. Expected values/Reference range:
The following literature reference values were provided;
Glucose¹ - normal = fasting 70-105 mg/dL
Fructosamine² - adult = 205-285 umol/L, child = 5% below adult levels
AST³ - males = 15-40 U/L, females = 13-35 U/L
1. American Diabetes Association; Diabetes Care, Volume 24 Supplement 1, Clinical practice Recommendations (2001).
2. Burtis, C.A. and Ashwood, E.R. Tietz Textbook of Clinical Chemistry, Second Edition, W.B. Saunders Company, 2189.
3. Siest, G.; et. al. Clin Chem 1975, 21, 1077-1087.
N. Proposed Labeling:
The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.
O. Conclusion:
The submitted information in this premarket notification is complete and supports a substantial equivalence decision.
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.
Copy this now. It will not be shown again.
Connected apps
Apps you authorized through browser sign-in. Disconnecting revokes their access immediately.
Learn the FDA Browser
Two short videos show you everything — or skip straight to the written tutorial if you'd rather read. You can reopen this any time from the Tutorial button in the top bar.
Part 1 — Search, results, and everyday workflows 16 min
Part 2 — Embeddings: the galaxy map 3 min
1. Search: exact and fuzzy
Type a phrase like "coronary artery calcification" into the search box. You get two kinds of results. Exact results match the literal phrase — prefix searches work ("coronary artery calcificati") but suffix searches do not. Fuzzy results match on the meaning and intent of your phrase rather than the exact words, and are sorted by relevance score. Hover over the Exact or Fuzzy badge on any row to see exactly why it matched.
Use the checkboxes above the results to narrow: SaMD keeps only software-only devices, AI / ML keeps only devices with AI.
Exact vs. fuzzy search: what's the difference?
Exact matches on the literal phrase (prefix search works, suffix does not). Fuzzy matches on the meaning and intent of the phrase rather than the exact words. Hover over the badge on any row to see why it matched.
You search "coronary artery calcification" and want only software devices with AI. What two filters do you apply?
Narrow by SaMD (software-only devices), then narrow by AI/ML (devices with AI).
2. The results table
Scroll right in the results table. The intended use is extracted for you — no need to open the PDF. The device story gives a high-level snapshot of what the device does and how it's used. The AI Performance sub-table shows each output name, acceptance criteria, observed values, and development/test dataset descriptions — the same format Innolitics uses for regulatory strategy outputs, and the fastest high-level fingerprint of an AI device. It is AI-generated but has been very reliable in practice.
Where do you find a device's intended use without opening the PDF?
Scroll right in the search results table. The intended use column is extracted for you; no need to dig into the 510(k) summary PDF.
What does the AI Performance sub-table show, and why is it useful?
Output name, acceptance criteria, observed values, development dataset description, and test dataset description. It's the same format we use for regulatory strategy output and Fast 510(k) input, and the fastest high-level fingerprint of an AI device. AI-generated but reliable in practice.
3. Judging fuzzy relevance
Fuzzy results trail off in relevance as you scroll. Use three signals to decide how far down to go: the fuzzy badge explanations, the intended use column, and whether your target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, you're past the relevant zone. A top hit with a low score (~0.4) and a stretched explanation is a hint the closest predicates are far away — the project may be headed for De Novo. Note the fuzzy search is a pattern match: it doesn't handle negation ("not") well, and hardware devices can appear — filter by SaMD/AI ML to cut them.
How do you judge how far down fuzzy search results to go?
Use the relevancy signals: the fuzzy badge explanations, the intended use column, and whether the target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, results are trailing off in relevancy.
4. Device detail page: chat and citations
Click a device name to open its detail page: device facts on the left, a chat window on the right. Ask something like "Describe the training data". The answer carries little citation bubbles — click one to jump to the highlighted passage in the source PDF, so you can verify every AI answer against the document. There's also a Download PDF button for sharing.
How do you verify an AI chat answer on the device detail page?
Click the citation bubbles to jump to the relevant highlight in the source document.
Reading rule for every project: how many summaries do you read in full?
At least the three most relevant 510(k) or De Novo summaries, in full. After that, use targeted chat questions to confirm your memory quickly. The tool supports this professional habit — it doesn't replace it.
5. Side-by-side comparison
Select multiple rows in the results table (aim for under ~10), then open the PDF Viewer tab. Ask one question — it goes to all selected devices in parallel, each with citations. This is the fastest way to compare and contrast devices: training data, PCCP scope, how they handled adding new scanners, and so on.
What does the side-by-side PDF viewer mode do?
Select multiple devices, open the PDF viewer tab, and ask one question (e.g., "Describe the training data"). It queries all selected devices simultaneously with citations, so you can compare and contrast quickly.
6. Collections
With rows selected, go to the Collections tab and create a labeled collection (e.g., "Cobb Angle Project"). Reload that selection any time — before a client call, pull up the collection and ask questions across all of its devices at once.
How do you save a set of selected devices for later use?
Select the rows, go to the Collections tab, and create a labeled collection (e.g., "Cobb Angle Project"). You can reload the selection anytime and carry it into the PDF viewer and other tabs that support selections.
7. Product codes and the regulations tree
Click a product code in the results to jump to it in the regulations tree — identification text, sibling product codes, and devices you can open in a PDF viewer on the right. Click a regulation number to see its identification, special controls, and related product codes. You can also search by product code or regulation number at the top of the tree. Always read the special controls if any exist for your device — it broadens your search and sharpens pre-kickoff research.
What can you do from the regulations tree view?
Browse product codes and regulation numbers, read the identification text and special controls, browse sibling product codes, open device PDFs on the right, and search by product code or regulation number at the top of the tree.
8. Chart view
Click Show Chart and segment by regulation number (or product code) to see which regulations dominate your result set. Clicking a regulation takes you into the regulations tree. Great for spotting that most matches are, say, hardware laparoscopic devices — a cue to go back and filter.
How do you see which regulations dominate a search result set?
Click "Show Chart" and segment by Regulation Number. Clicking a regulation takes you to the regulations tree.
9. The predicate graph
Open the Predicates tab for a family-tree view of predicate relationships. Click a node to trace its parents and children; selections from search carry over pre-selected. Commonly predicated devices are worth reading — a lot of people predicated them for a reason. The visual lineage is also handy on client calls, e.g. to show how a predicate family evolved and justify why your predicate still holds.
In the predicate graph, why are commonly predicated devices worth reading?
A lot of people predicated them for a reason. Clicking a node traces parents and children, and selections from search carry over pre-selected.
10. Embeddings: the galaxy map
The Embeddings tab plots every matching document in a 2-D "galaxy map" where semantically similar devices cluster together. Hover or click clusters to explore, and let AI label the clusters for you. Embeddings beat product codes for grouping: two devices can carry different product codes (LLZ vs. QIH) yet do the same thing — the embedding captures the meaning of the intended use and device story. This is also exactly how retrieval-augmented generation (RAG) works under the hood, and it makes a great visual on client calls.
Try it yourself
Head to the search page and work through a few of these AI/ML fuzzy searches to build intuition: perivascular fat on CT · aortic valve calcification opportunistic screening on noncontrast CT · breast cancer prediction on digital pathology slides · autism detection · gestational age prediction · a hearing aid that can also detect a pulse · foundation model based analysis of ECG · large language models · penetration test. Watch how the relevance scores, intended use, and AI Performance tables tell you when results stop being meaningful.